Xconomy » VentureDeal http://www.xconomy.com Business + Technology in the Exponential Economy Sun, 22 Nov 2009 19:59:19 +0000 http://wordpress.org/?v=2.8.6 en hourly 1 Corindus Lands $5,300,000 New Funding Round http://www.xconomy.com/boston/2009/11/19/corindus-lands-5300000-new-funding-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/boston/2009/11/19/corindus-lands-5300000-new-funding-round/ BostonVC, Undisclosed, Corindus VentureDeal wrote:
  • Feed Type
  • Date
    11/19/2009
  • Company Name
    Corindus
  • Mailing Address
    11 Erie Drive Natick, MA 01760
  • Company Description
    Corindus provides intuitive robotic technologies for catheterization laboratories and radiology/special procedure suites. Allowing physicians to accurately place guide wires and precisely deploy stent systems in patient’s arteries from a comfortable workstation; enabling operators to conduct interventions in a safe and convenient operating environment.
  • Website
    http://www.corindus.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share

UNDERWRITERS AND PARTNERS

]]> http://www.xconomy.com/boston/2009/11/19/corindus-lands-5300000-new-funding-round/feed/ Ligon Discovery Receives $1,000,000 New Funding Round http://www.xconomy.com/boston/2009/11/19/ligon-discovery-receives-1000000-new-funding-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/boston/2009/11/19/ligon-discovery-receives-1000000-new-funding-round/ BostonVC, Ligon Discovery, incTANK VentureDeal wrote:
  • Feed Type
  • Date
    11/19/2009
  • Company Name
    Ligon Discovery
  • Mailing Address
    64 Sidney Street Cambridge, MA 02139
  • Company Description
    Ligon Discovery’s primary technology platform, Small-Molecule Microarrays (SMMs), fundamentally transforms drug discovery by bringing the power of microarrays to target screening.
  • Website
    http://www.ligondiscovery.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    incTANK
Comments | Reprints | Share:   Retweet  Facebook  Email  Share


]]> http://www.xconomy.com/boston/2009/11/19/ligon-discovery-receives-1000000-new-funding-round/feed/ ShoeDazzle.com Garners $7,000,000 New Funding http://www.xconomy.com/san-diego/2009/11/18/shoedazzle-com-garners-7000000-new-funding/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/18/shoedazzle-com-garners-7000000-new-funding/ ShoeDazzle.com, SanDiegoVC, Undisclosed VentureDeal wrote:
  • Feed Type
  • Date
    11/18/2009
  • Company Name
    ShoeDazzle.com
  • Mailing Address
    3530 Wilshire Blvd Los Angeles, CA 90010
  • Company Description
    ShoeDazzle’s fashion experts choose the hottest shoes for you every month based on YOUR individual personality and tastes. The shoes we pick for you will express your individuality and sense of style. Distinctive, yet trend-right.
  • Website
    http://www.shoedazzle.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/18/shoedazzle-com-garners-7000000-new-funding/feed/ PPD Acquires BioDuro for Undisclosed Sum http://www.xconomy.com/san-diego/2009/11/18/ppd-acquires-bioduro-for-undisclosed-sum/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/18/ppd-acquires-bioduro-for-undisclosed-sum/ SanDiegoMA, BioDuro VentureDeal wrote:
  • Feed Type
  • Date
    11/18/2009
  • Company Name
    BioDuro
  • Mailing Address
    9710 Scranton Road San Diego, CA 92121
  • Company Description
    BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing, China. Our priority is providing the highest quality, FDA-compliant services at an affordable cost. Our clients are over 40 pharmaceutical and biotechnology companies, and our services span the entire range of drug discovery and development, from discovery chemistry, through pharmacology and drug safety and evaluation, to clinical trials. Today, BioDuro is working with 10 of the 12 largest pharmaceutical companies in the world.
  • Website
    http://www.bioduro.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    “This acquisition will strengthen PPD’s presence in China and our ability to provide clients an extensive range of services in this country. It will also position us well to provide services for the growing global discovery outsourcing industry and to be the full-service CRO of choice in China.”
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/18/ppd-acquires-bioduro-for-undisclosed-sum/feed/ Active Storage Receives Series A Round http://www.xconomy.com/san-diego/2009/11/17/active-storage-receives-series-a-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/17/active-storage-receives-series-a-round/ Intel Capital, Valhalla Partners, SanDiegoVC VentureDeal wrote:
  • Feed Type
  • Date
    11/17/2009
  • Company Name
    Active Storage
  • Mailing Address
    2295 Jefferson St Torrance, CA 90501
  • Company Description
    We formed Active Storage because we saw an unfilled need for easy-to-use high performance storage for Apple users. As a team of storage veterans with many award-winning and innovative products behind us, we believe that with the right mix of hard work, dedication and an innovative spirit we can make a difference and deliver the best user experience possible while offering a compelling price/performance advantage. We know storage and we know user needs. We understand that we cannot be everything to everyone, so we have chosen to be the best in the Apple marketplace.
  • Website
    http://www.getactivestorage.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Intel Capital
  • Venture Investor
    Mission Ventures
  • Venture Investor
    Valhalla Partners
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/17/active-storage-receives-series-a-round/feed/ NextImage Medical Garners $5,000,000 Series A Funding http://www.xconomy.com/san-diego/2009/11/17/nextimage-medical-garners-5000000-series-a-funding/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/17/nextimage-medical-garners-5000000-series-a-funding/ Undisclosed, SanDiegoVC, Chrysalis Ventures VentureDeal wrote:
  • Feed Type
  • Date
    11/17/2009
  • Company Name
    NextImage Medical
  • Mailing Address
    3398 Carmel Mountain Road San Diego, CA 92121
  • Company Description
    NextImage Medical and our radiology partners are committed to lowering the cost of radiology care through the entire continuum of care. We feel that our cooperative model is the answer to the healthcare industry’s demand for high-quality, low-cost radiology. Harnessing the advances in healthcare technology, NextImage Medical has built the most advanced and innovative delivery system for radiology services. NextImage’s proprietary model is the ideal solution for the current and pending crisis of unbalanced quality, availability, and cost of radiology services.
  • Website
    http://www.nextimagemedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the capital to accelerate its market expansion and enhance its technology platform.
  • M&A Terms
  • Venture Investor
    Chrysalis Ventures
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/17/nextimage-medical-garners-5000000-series-a-funding/feed/ Swipely Receives $875,000 New Financing http://www.xconomy.com/boston/2009/11/16/swipely-receives-875000-new-financing/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/boston/2009/11/16/swipely-receives-875000-new-financing/ BostonVC, First Round Capital, Swipely VentureDeal wrote:
  • Feed Type
  • Date
    11/16/2009
  • Company Name
    Swipely
  • Mailing Address
    150 Chestnut Street Providence, RI 02903
  • Company Description
    Swipely is a Tech & Digital Media Community.
  • Website
    http://www.swipely.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $875,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    First Round Capital
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/boston/2009/11/16/swipely-receives-875000-new-financing/feed/ DocuSign Receives New Round http://www.xconomy.com/seattle/2009/11/16/docusign-receives-new-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/seattle/2009/11/16/docusign-receives-new-round/ DocuSign, Second Century Ventures, SeattleVC VentureDeal wrote:
  • Feed Type
  • Date
    11/16/2009
  • Company Name
    DocuSign
  • Mailing Address
    701 Fifth Avenue Seattle, WA 98104
  • Company Description
    DocuSign was founded in 2003 with one goal: to make electronic signatures as ubiquitous and simple as email. DocuSign delivers the final step in the online customer relationship—the ability to complete a legally binding agreement over the internet.
  • Website
    http://www.docusign.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The cash will be used to speed up and extend DocuSign’s efforts with residential and commercial real estate customers.
  • M&A Terms
  • Venture Investor
    Second Century Ventures
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/seattle/2009/11/16/docusign-receives-new-round/feed/ Global Analytics Lands $10,000,000 New Round http://www.xconomy.com/san-diego/2009/11/16/global-analytics-lands-10000000-new-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/16/global-analytics-lands-10000000-new-round/ Undisclosed, SanDiegoVC, Global Analytics VentureDeal wrote:
  • Feed Type
  • Date
    11/16/2009
  • Company Name
    Global Analytics
  • Mailing Address
    5230 Carroll Canyon Road San Diego, CA 92121
  • Company Description
    Analytic solutions are now part of mainstream business processes. In many industries, the use of analytics has matured to a point where it is impossible to compete without them. Analytics is now at a point where it’s not enough to collect the right data . and it’s not enough to build predictive models “right”. Today, real advantage depends upon building the right analytic solutions; real advantage requires game-changing analytic solutions.
  • Website
    http://www.global-analytics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/16/global-analytics-lands-10000000-new-round/feed/ Fate Therapeutics Lands $30,000,000 Series B Funding Round http://www.xconomy.com/san-diego/2009/11/16/fate-therapeutics-lands-30000000-series-b-funding-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/16/fate-therapeutics-lands-30000000-series-b-funding-round/ Polaris Venture Partners, Venrock, ARCH Venture Partners VentureDeal wrote:
  • Feed Type
  • Date
    11/16/2009
  • Company Name
    Fate Therapeutics
  • Mailing Address
    10931 North Torrey Pines Road La Jolla, CA 92037
  • Company Description
    The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s reprogramming medicine platform involves developing drugs to reprogram mature adult cells into stem cells which when differentiated can become healthy heart, bone, brain or other tissues.
  • Website
    http://www.fatetherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company is looking to complete enrollment in the initial clinical trial of FT-1050 by next spring.
  • M&A Terms
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Venrock
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/16/fate-therapeutics-lands-30000000-series-b-funding-round/feed/ Avnera Corporation Secures $8,000,000 New Funding Round http://www.xconomy.com/seattle/2009/11/13/avnera-corporation-secures-8000000-new-funding-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/seattle/2009/11/13/avnera-corporation-secures-8000000-new-funding-round/ Undisclosed, SeattleVC, Avnera Corporation VentureDeal wrote:
  • Feed Type
  • Date
    11/13/2009
  • Company Name
    Avnera Corporation
  • Mailing Address
    16505 NW Bethany Ct Beaverton, OR 97006
  • Company Description
    Avnera is a fabless semiconductor company founded in June 2004 in Beaverton, Oregon. It has pioneered a new semiconductor technology enabling breakthrough products for wireless audio and Voice-over-IP (VoIP) applications that remove the pain-points associated with today’s wireless audio technology.
  • Website
    http://www.avnera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/seattle/2009/11/13/avnera-corporation-secures-8000000-new-funding-round/feed/ Widevine Technologies Lands $7,250,000 New Round http://www.xconomy.com/seattle/2009/11/12/widevine-technologies-lands-7250000-new-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/seattle/2009/11/12/widevine-technologies-lands-7250000-new-round/ VantagePoint Venture Partners, SeattleVC, Constellation Growth Fund VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Widevine Technologies
  • Mailing Address
    901 5th Avenue Seattle, WA 98164
  • Company Description
    Widevine is the most widely deployed provider of content security solutions for IP video operators worldwide. Widevine enables telco, cable, fiber, satellite, internet and wireless service operators to generate new revenue opportunities through the secure distribution, identification and tracking of digital content.
  • Website
    http://www.widevine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,250,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Constellation Growth Fund
  • Venture Investor
    VantagePoint Venture Partners
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/seattle/2009/11/12/widevine-technologies-lands-7250000-new-round/feed/ Redfin Corporation Garners $10,000,000 Series D Funding http://www.xconomy.com/seattle/2009/11/12/redfin-corporation-garners-10000000-series-d-funding/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/seattle/2009/11/12/redfin-corporation-garners-10000000-series-d-funding/ Madrona Venture Group, Hillman Company, SeattleVC VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Redfin Corporation
  • Mailing Address
    710 2nd Avenue Seattle, WA 98104
  • Company Description
    Redfin is the industry’s first online real estate brokerage. Unlike any other real estate site, Redfin lets you buy and sell MLS-listed homes online. You can shop for homes and browse prices using our map-driven home-shopping site, then make an offer or list a property via Redfin Direct, Redfin’s step-by-step guide to buying or selling your home.
  • Website
    http://www.redfin.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Redfin plans to use the additional capital to scale its infrastructure for delivering extremely high levels of customer service, to expand into new markets and to invest in research and development.
  • M&A Terms
  • Venture Investor
    Greylock Partners
  • Venture Investor
    Madrona Venture Group
  • Venture Investor
    Draper Fisher Jurvetson
  • Venture Investor
    Vulcan Ventures
  • Venture Investor
    Hillman Company
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/seattle/2009/11/12/redfin-corporation-garners-10000000-series-d-funding/feed/ Cyntellect Obtains $15,500,000 New Financing http://www.xconomy.com/san-diego/2009/11/12/cyntellect-obtains-15500000-new-financing/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/12/cyntellect-obtains-15500000-new-financing/ Undisclosed, SanDiegoVC, Cyntellect VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Cyntellect
  • Mailing Address
    6620 Mesa Ridge Road San Diego, CA 92121
  • Company Description
    Cyntellect is a company dedicated to commercializing platform solutions and services, that will enable scientists to efficiently and accurately exploit living cells. The company has launched commercial products and services and has established business relationships with leading academic and commercial institutions in life sciences.
  • Website
    http://www.cyntellect.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/12/cyntellect-obtains-15500000-new-financing/feed/ Six Degrees Games Receives $7,000,000 Series B Funding Round http://www.xconomy.com/san-diego/2009/11/12/six-degrees-games-receives-7000000-series-b-funding-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/12/six-degrees-games-receives-7000000-series-b-funding-round/ Prism VentureWorks, Time Warner Investments, SanDiegoVC VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Six Degrees Games
  • Mailing Address
    4223 Glencoe Boulevard Marina Del Rey, CA 90292
  • Company Description
    Six Degrees Games, Inc. is a video game and virtual world publisher for major video game systems and personal computers.
  • Website
    http://www.sixdegreesgames.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The additional funding will be used to accelerate Six Degrees Games’ growth in the sports entertainment space and to enhance in-house development capabilities.
  • M&A Terms
  • Venture Investor
    Time Warner Investments
  • Venture Investor
    Clearstone Venture Partners
  • Venture Investor
    Prism VentureWorks
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/12/six-degrees-games-receives-7000000-series-b-funding-round/feed/ Altair Therapeutics Receives $17,000,000 New Financing Round http://www.xconomy.com/san-diego/2009/11/12/altair-therapeutics-receives-17000000-new-financing-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/12/altair-therapeutics-receives-17000000-new-financing-round/ Undisclosed, Thomas, McNerny & Partners, SanDiegoVC VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Altair Therapeutics
  • Mailing Address
    12555 High Bluff Drive San Diego, CA 92130
  • Company Description
    Altair is building a dedicated team, combining antisense drug discovery expertise with respiratory drug development expertise, to focus solely on the development and commercialization of antisense drugs for the treatment of asthma and other respiratory conditions.
  • Website
    http://www.altairtherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Altair Therapeutics will use the funding to complete phase 2a trials for its lead product, inhaled AIR645 and advance research and development in new target programs.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    Thomas, McNerny & Partners
  • Venture Investor
    Forward Ventures
  • Venture Investor
    Isis Pharmaceuticals
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/12/altair-therapeutics-receives-17000000-new-financing-round/feed/ Yidio Obtains $500,000 New Financing http://www.xconomy.com/san-diego/2009/11/12/yidio-obtains-500000-new-financing/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/san-diego/2009/11/12/yidio-obtains-500000-new-financing/ Yidio, SanDiegoVC, Undisclosed VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Yidio
  • Mailing Address
    7770 Regents Rd San Diego, CA 92122
  • Company Description
    Through the website Yidio.com, users have the ability to search for any video based on topic, category, or source. Videos offered on Yidio.com range from full TV shows to full movies, celebrity gossip, sports, and music videos.
  • Website
    http://www.yidio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/san-diego/2009/11/12/yidio-obtains-500000-new-financing/feed/ Doxo Obtains $5,250,000 New Round http://www.xconomy.com/seattle/2009/11/12/doxo-obtains-5250000-new-round/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/seattle/2009/11/12/doxo-obtains-5250000-new-round/ Mohr Davidow Ventures, Undisclosed, SeattleVC VentureDeal wrote:
  • Feed Type
  • Date
    11/12/2009
  • Company Name
    Doxo
  • Mailing Address
    206 1st Ave S Seattle, WA 98104
  • Company Description
    doxo™ is developing an innovative solution to an age-old problem – a simple and efficient system that addresses a multi-billion dollar business problem and a market opportunity with global impact. And on top of all that, it’s good for the planet.
  • Website
    http://www.doxo.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,250,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Mohr Davidow Ventures
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/seattle/2009/11/12/doxo-obtains-5250000-new-round/feed/ HP Acquires 3Com Corporation for $2,700,000,000 http://www.xconomy.com/boston/2009/11/11/hp-acquires-3com-corporation-for-2700000000/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/boston/2009/11/11/hp-acquires-3com-corporation-for-2700000000/ 3Com Corporation, BostonMA VentureDeal wrote:
  • Feed Type
  • Date
    11/11/2009
  • Company Name
    3Com Corporation
  • Mailing Address
    350 Campus Drive Marlborough, MA 01752-3064
  • Company Description
    Throughout our 30-year history, 3Com has been an innovator in developing networks for global enterprises of all sizes. Since the company’s inception and delivery of its first Ethernet transceiver and adapter, 3Com has consistently offered customer-driven technology solutions that help enterprises optimize their budgets and resources, increase productivity, and realize their business goals.
  • Website
    http://www.3com.com
  • Transaction Type
    M&A
  • Transaction Amount
    $2,700,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    HP and 3Com announced that they have entered into a definitive agreement under which HP will purchase 3Com, a leading provider of networking switching, routing and security solutions, at a price of $7.90 per share in cash or an enterprise value of approximately $2.7 billion. The terms of the transaction have been approved by the HP and 3Com boards of directors.
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/boston/2009/11/11/hp-acquires-3com-corporation-for-2700000000/feed/ BioVex Garners $30,000,000 Series F Funding http://www.xconomy.com/boston/2009/11/10/biovex-garners-30000000-series-f-funding/ Tue, 30 Nov 1999 05:00:00 +0000 VentureDeal http://www.xconomy.com/boston/2009/11/10/biovex-garners-30000000-series-f-funding/ BioVex, Ventech, BostonVC VentureDeal wrote:
  • Feed Type
  • Date
    11/10/2009
  • Company Name
    BioVex
  • Mailing Address
    34 Commerce Way Woburn, MA 01801
  • Company Description
    The Company is developing a new class of potent biologics for the treatment
    of cancer and prevention of infectious disease.
  • Website
    http://www.biovex.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series F
  • Proceeds Purposes
    The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.
  • M&A Terms
  • Venture Investor
    Morningside Group
  • Venture Investor
    Ventech
  • Venture Investor
    MVM Life Science Partners
  • Venture Investor
    Undisclosed
Comments | Reprints | Share:   Retweet  Facebook  Email  Share
]]> http://www.xconomy.com/boston/2009/11/10/biovex-garners-30000000-series-f-funding/feed/